TLIK.F up 15% intraday 13 Feb 2026 (Arzneiwerk AG XETRA): key outlook

TLIK.F stock led XETRA gainers on 13 Feb 2026, jumping 15.15% to €0.38 intraday. The move followed a low-volume gap from €0.26 at the open, with 600 shares traded versus a 50-day average volume of 656. Arzneiwerk AG VIDA (TLIK.F) trades on XETRA in Germany and remains highly volatile. We examine why price moved, how fundamentals stack up, and what our models project for short-term traders.

TLIK.F stock intraday price action and volume

TLIK.F stock rose 15.15% to €0.38 on 13 Feb 2026 on XETRA. The session range was €0.26 to €0.38, signalling a recovery from the open. Volume stayed light at 600 shares, near the average 656, so momentum needs confirmation in higher liquidity.

TLIK.F stock fundamentals and valuation

Arzneiwerk AG VIDA reports EPS -€0.11 and a PE of -3.45, reflecting recent losses. Market capitalisation stands at €2,368,700.00 with 6,233,420 shares outstanding. Key ratios show weak liquidity with a current ratio of 0.04 and free cash flow per share -€0.34, underscoring balance sheet stress.

TLIK.F stock technical setup and moving averages

Price trades above the 50-day average €0.31 and near the 200-day average €0.37, creating a short-term bullish bias. Immediate resistance sits at the year high €0.69. A close above €0.38 on higher volume would support a run to €0.60.

Meyka AI grade and TLIK.F stock forecast

Meyka AI rates TLIK.F with a score out of 100: 62.66 (Grade B, HOLD). This grade factors S&P 500 and sector comparison, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a monthly price of €0.27, an implied downside of -28.95% versus the current €0.38. Forecasts are model-based projections and not guarantees.

TLIK.F stock sector context and catalysts

TLIK.F sits in Healthcare, Medical – Distribution, a sector with modest YTD performance of 0.46%. Catalysts include regulatory approvals or supply contracts for rare medicines. Sector momentum is mixed, so company-specific news will drive short-term moves more than sector flows.

TLIK.F stock risks and trading considerations

Major risks include low liquidity, negative cash flow, and limited staff with two full-time employees. Receivables turnover and working capital metrics show stress. Traders should size positions for high volatility and monitor filings and press releases on the company website and exchange notices.

Final Thoughts

Intraday, TLIK.F stock led small-cap movers on XETRA, rising 15.15% to €0.38 on 13 Feb 2026. The rise came on light volume, and fundamentals remain weak with EPS -€0.11, a negative PE, and a thin current ratio 0.04. Meyka AI’s grade of 62.66 (B, HOLD) flags mixed signals between short-term momentum and poor financial health. Our model projects €0.27 monthly, implying -28.95% versus the current level, while a conservative target of €0.20 implies -47.37% and an optimistic target of €0.60 implies +57.89%. Given the company’s small market cap €2,368,700.00 and limited free cash flow, we advise cautious, short-horizon trades and strict risk limits. For traders, watch volume above 656 shares and any company updates on XETRA for confirmation.

FAQs

What drove the intraday jump in TLIK.F stock today?

The intraday gain came with a gap from €0.26 to €0.38 and modest volume of 600 shares. No major public earnings were posted; short-covering or a liquidity trade likely pushed the price higher on XETRA.

What is Meyka AI’s short-term forecast for TLIK.F stock?

Meyka AI’s forecast model projects a monthly price of €0.27, an implied downside of -28.95% versus the current €0.38. Forecasts are model-based projections and not guarantees.

Should investors buy TLIK.F stock after the intraday rise?

Given weak liquidity, negative EPS, and low current ratio, Meyka AI assigns a B (HOLD) grade. Investors should prioritise risk control and await clearer volume-backed moves or company updates.

What price targets and risks apply to TLIK.F stock?

We outline a conservative target €0.20 (-47.37%) and an optimistic target €0.60 (+57.89%). Key risks are low liquidity, negative cash flow, and limited corporate scale.

Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.